Self-Hypnosis Decreases Gynecologic Cancer Surgery Anxiety
With prior research indicating that self-hypnosis (SH) may help reduce preoperative distress and...
Read MoreMar 18, 2022
With prior research indicating that self-hypnosis (SH) may help reduce preoperative distress and...
Read MoreMar 15, 2022
Across histologies other than clear cell, Black women with stage 1 endometrial cancer experienced...
Read MoreMar 14, 2022
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and incidence...
Read MoreMar 11, 2022
From the Physician Editor-in-Chief Euthanasia has long been a controversial topic. The...
Read MoreMar 11, 2022
Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein-antibody...
Read MoreMar 9, 2022
This course describes the newest recommendations on preferred and alternative treatments for...
Read MoreMar 9, 2022
This course discusses the differences between guideline-based recommendations for common...
Read MoreMar 8, 2022
In patients with MS, dysfunctional visual search behavior may be one of the mechanisms that...
Read MoreMar 8, 2022
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read MoreMar 7, 2022
Liver cancer is the third-highest cause of cancer-related deaths worldwide, and incidence of...
Read MoreMar 7, 2022
When compared with the general population, patients with cancer-associated thrombosis (CAT) have...
Read MoreMar 3, 2022
In patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors...
Read MoreMar 1, 2022
This course discusses a study that evaluated the relationship between extended hang times of...
Read MoreFeb 25, 2022
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read MoreFeb 24, 2022
Among children diagnosed with MS, parental HRQOL mediates the relationship between that diagnosis...
Read MoreFeb 23, 2022
Updated data from the KEYNOTE-564 trial shows pembrolizumab disease-free survival persists long...
Read MoreFeb 23, 2022
Combination treatment with nivolumab plus axitinib has achieved a high response rate in...
Read MoreFeb 23, 2022
Biomarker analysis of the phase 2 TITAN-RCC trial identified specific immune cell-related...
Read MoreFeb 23, 2022
Results of the NeoAvAx trial indicate that the neoadjuvant combination of avelumab plus axitinib...
Read MoreFeb 23, 2022
In order to successfully navigate the ins and outs of necessities like insurance, technology...
Read More